Physical Exercise for Patients With Head and Neck Cancer
VITAL
The Effect of Physical Exercise During Radiotherapy on Physical Functioning in Patients With Head and Neck Cancer: a Trial Within Cohorts, the VITAL Study
1 other identifier
interventional
112
1 country
1
Brief Summary
The goal of this trial within cohorts study is to determine and compare physical performance, muscle strength, fatigue, quality of life, body composition, nutritional status, physical activity, treatment tolerability of radiotherapy (RT), chemoradiation (CRT) or bioradiation (BRT), and healthcare related costs in patients with head and neck cancer (HNC) with and without a 10 week physical exercise intervention (PEI) during RT, CRT or BRT ((C/B)RT). Patients who were randomized in the PEI group and accepted the invitation to undergo the experimental intervention receive a PEI twice a week for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT. Researchers will compare patients who undergo the PEI with patients who did not undergo the PEI to see if there is difference in physical performance, muscle strength, fatigue, Quality of Life, body composition, nutritional status, physical activity, treatment tolerability of (C/B)RT , and healthcare related costs in patients with Head and Neck Cancer (HNC) with and without a 10 week Physical Exercise Intervention (PEI) during (C/B)RT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable head-and-neck-cancer
Started Nov 2022
Typical duration for not_applicable head-and-neck-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 9, 2022
CompletedFirst Submitted
Initial submission to the registry
July 20, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 9, 2026
ExpectedAugust 14, 2023
August 1, 2023
3 years
July 20, 2023
August 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
physical performance
six minute walking test
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
Secondary Outcomes (12)
Muscle strength
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
Muscle strength
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
Muscle strength
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
Health Related Quality of Life
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
Health Related Quality of Life
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
- +7 more secondary outcomes
Study Arms (2)
Patients who were randomized in the PEI group and accepted the invitation
EXPERIMENTALThe experimental intervention consist of a PEI for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT.
Patients who were not randomized in the PEI group
NO INTERVENTIONPatients will receive usual care.
Interventions
Patients who were randomized in the PEI group and accepted the invitation to undergo the experimental intervention receive a PEI for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT. The PEI consists of a 60 minutes intervention twice a week and will be supervised by a physiotherapist specialized in oncology. Patients who receive the intervention also have to do home-based aerobic and muscle strength exercises by themselves three times a week.
Eligibility Criteria
You may qualify if:
- patients with HNC who are scheduled for (C/B)RT,
- ≥18 years of age,
- sufficient Dutch writing and reading skills,
- a Karnofsky performance status (KPS) \>60,
- able to walk ≥60m without a mobility aid, and
- no contraindication for physical activity as measured with the physical activity readiness questionnaire (PAR-Q).
You may not qualify if:
- recurrence of HNC and/or
- secondary HNC.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institute Verbeetenlead
- Verbeeten Fondscollaborator
- Stichting Fight Cancercollaborator
- CZ Fondscollaborator
Study Sites (1)
Instituut Verbeeten
Tilburg, North Brabant, 5042 SB, Netherlands
Related Publications (1)
Kriellaars Y, Vermaire JA, Beugeling M, Poorter R, Drijvers J, Speksnijder CM. The effect of physical exercise during radiotherapy on physical performance in patients with head and neck cancer: a trial within cohorts study protocol, the vital study. BMC Cancer. 2024 Apr 1;24(1):403. doi: 10.1186/s12885-024-12172-2.
PMID: 38561708DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yvette Kriellaars, Msc.
Instituut Verbeeten
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2023
First Posted
August 14, 2023
Study Start
November 9, 2022
Primary Completion
November 9, 2025
Study Completion (Estimated)
November 9, 2026
Last Updated
August 14, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share